Call for new drug discovery pilot projects at SciLifeLab DDD with special emphasis on biologics and antibiotics
June 28, 2023 @ 11:00 – 12:00 CEST
The DDD platform at SciLifeLab supports academic drug discovery project with expertise and technical capabilities. We have, for example, platforms to develop small molecule drugs, therapeutic antibodies, oligonucleotide therapeutics, proximity-inducing agents such as bispecific antibodies and PROTACs.
In this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new pilot project proposals for drug discovery. All therapeutic modalities outlined above are of interest. Of special interest are new project ideas for (multispecific) biologics, and in collaboration with ENABLE2 https://www.ilk.uu.se/enable2/, small molecule projects for discovery of new antibiotics.
Note that small projects for selections in phage display libraries for antibodies, selections in DNA encoded chemical libraries for small molecules or limited screening for antisense or siRNA molecules can be considered.
A description of new modalities in drug discovery research can be found here: https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00582
If you have questions about the call please contact DDD by email (email@example.com). This call is open for scientists with a doctoral degree at a Swedish university or higher institution. English should be used when filling out this application. You are responsible for ensuring that the application is complete. Incomplete applications will not be processed.
11.00 Introduction to Anubis call for DDD pilot-projects, Per Arvidsson
11.05 Oligonucleotide therapeutics through OligoNova HUB at DDD, Pär Matsson
11.30 Questions & Answers
11.45 End with a video about collaboration with SciLifeLab DDD featuring Marika Nestor, Uppsala University